Great find, also on Forbes now. With IHL-675A being a combination treatment consisting of hydroxychloroquine and cannabidiol, with the two components working synergistically, the potential for a unique drug for the prevention and treatment of Covid related inflammatory lung conditions looks very promising. Apart from the multi purpose efficacy for rheumatoid arthritis and inflammatory bowel disease.
- Forums
- ASX - By Stock
- IHL
- Ann: Update on Nasdaq Listing
Ann: Update on Nasdaq Listing, page-147
-
- There are more pages in this discussion • 605 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)